FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to hepatology, transplantology, and can be used to correct liver failure in a subject. To do this, the total RNA extracted from the multipotent mesenchymal stromal cells of the mammal's bone marrow is used.
EFFECT: invention allows to increase effectiveness of treatment of hepatic insufficiency and prevent the development of complications associated with the use of biotechnological methods of correction and prevention of hepatic insufficiency by stem/progenitor cells.
3 cl, 2 tbl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CORRECTION OF HEPATIC INSUFFICIENCY IN THE EXPERIMENT | 2017 |
|
RU2650209C1 |
METHOD OF TREATING HEPATIC FAILURE | 2017 |
|
RU2655528C1 |
METHOD OF CHRONIC HEPATIC FAILURE CORRECTION | 2020 |
|
RU2739996C1 |
METHOD OF TREATING ACUTE HEPATIC IMPAIRMENT | 2018 |
|
RU2701792C1 |
METHOD OF TREATMENT OF ACUTE LIVER FAILURE | 2020 |
|
RU2744846C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425645C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425646C1 |
TREATMENT METHOD OF LIVE FAILURE | 2016 |
|
RU2618989C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425648C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425647C1 |
Authors
Dates
2018-05-29—Published
2017-08-08—Filed